“Multiple myeloma red flag”的搜索结果，显示 141-150 项，共有 11007 项

1. 血液科- 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

3. 血液科- 临床试验- 妙佑医疗国际

   A Study of JNJ‐68284528 Out‐of‐Specification (OOS) for Commercial Release in Patients with Multiple Myeloma. Rochester, Minn. The purpose of this study is to ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This clinical trial evaluates the impact of preexisting and therapy-emergent germline and somatic variants on cytopenia in patients with multiple myeloma or ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This clinical trial evaluates the impact of preexisting and therapy-emergent germline and somatic variants on cytopenia in patients with multiple myeloma or ...

6. Mayo Clinic Neurosciences Physician Update — July 2025

   Page 1.

7. 血液科- 临床试验- 妙佑医疗国际

   A Study To Examine The Effects Of Novel Therapy Linvoseltamab In Combination With Other Cancer Treatments For Adult Patients With Multiple Myeloma That Is ...

8. 血液科- 临床试验- 妙佑医疗国际

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

9. 血液科- 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...